AMLOGENYX Trademark
Trademark Overview
On Wednesday, September 11, 2024, a trademark application was filed for AMLOGENYX with the United States Patent and Trademark Office. The USPTO has given the AMLOGENYX trademark a serial number of 98745228. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 15, 2025. This trademark is owned by Amlogenyx Inc.. The AMLOGENYX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing medical services, namely, gene therapy medical services in the field of neurological and genetic diseases and disorders; medical consultations in the field of neurological and genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of neurological and genetic diseases and disorders, and collecting data and information on neurological and genetic diseases and disorders for screening, diagnosis and treatment purposes; medical information services in the nature of providing a database in the field of neurological and genetic diseases and disorder information based on collected patient data and information all for treatment and diagnostic purposes
General Information
| Serial Number | 98745228 |
| Word Mark | AMLOGENYX |
| Filing Date | Wednesday, September 11, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, April 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 15, 2025 |
Trademark Statements
| Goods and Services | Providing medical services, namely, gene therapy medical services in the field of neurological and genetic diseases and disorders; medical consultations in the field of neurological and genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of neurological and genetic diseases and disorders, and collecting data and information on neurological and genetic diseases and disorders for screening, diagnosis and treatment purposes; medical information services in the nature of providing a database in the field of neurological and genetic diseases and disorder information based on collected patient data and information all for treatment and diagnostic purposes |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Amlogenyx Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Party Name | Amlogenyx Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
Trademark Events
| Event Date | Event Description |
| Wednesday, September 11, 2024 | NEW APPLICATION ENTERED |
| Friday, January 24, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 12, 2025 | ASSIGNED TO EXAMINER |
| Friday, March 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 14, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, March 14, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 21, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 15, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 15, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
